AV

Advanced Oncotherapy PLCLSE Advanced Oncotherapy Stock Report

Last reporting period 30 Jun, 2022

Updated —

Last price

Market cap $B

0.013

Micro

Exchange

XLON - London Stock Exchange

View Section: Eyestock Rating

Advanced Oncotherapy Fair Value

AV

AVO.L stock is not valued by Eyestock.

The company does not have a valuation due to the unstable frequency of reports

Discover Undervalued Companies


Advanced Oncotherapy Valuation

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Min value

Max value

13.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

Advanced Oncotherapy PLC price metrics

-55.53

Annual return (geometric mean)

58.99

Risk (standard deviation) of returns

β

0.23

Beta (volatility compared to market)

It means that AVO.L stock is less volatile than the broader market
View Section: Profitability